- Home
- RCL vs ZTS Comparison
RCL vs ZTS Comparison
Compare RCL & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCL
- ZTS
- Stock Information
- Founded
- RCL 1968
- ZTS 1952
- Country
- RCL United States
- ZTS United States
- Employees
- RCL N/A
- ZTS N/A
- Industry
- RCL Marine Transportation
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- RCL Consumer Discretionary
- ZTS Health Care
- Exchange
- RCL Nasdaq
- ZTS Nasdaq
- Market Cap
- RCL 63.0B
- ZTS 75.1B
- IPO Year
- RCL N/A
- ZTS 2013
- Fundamental
- Price
- RCL $272.38
- ZTS $157.13
- Analyst Decision
- RCL Strong Buy
- ZTS Buy
- Analyst Count
- RCL 18
- ZTS 8
- Target Price
- RCL $279.00
- ZTS $211.50
- AVG Volume (30 Days)
- RCL 1.9M
- ZTS 2.8M
- Earning Date
- RCL 07-24-2025
- ZTS 08-05-2025
- Dividend Yield
- RCL 0.90%
- ZTS 1.27%
- EPS Growth
- RCL 60.94
- ZTS 7.32
- EPS
- RCL 12.30
- ZTS 5.57
- Revenue
- RCL $16,756,000,000.00
- ZTS $9,286,000,000.00
- Revenue This Year
- RCL $10.36
- ZTS $3.54
- Revenue Next Year
- RCL $9.45
- ZTS $6.11
- P/E Ratio
- RCL $22.16
- ZTS $28.22
- Revenue Growth
- RCL 13.66
- ZTS 6.32
- 52 Week Low
- RCL $130.08
- ZTS $139.70
- 52 Week High
- RCL $279.89
- ZTS $200.33
- Technical
- Relative Strength Index (RSI)
- RCL 63.43
- ZTS 39.98
- Support Level
- RCL $261.01
- ZTS $154.54
- Resistance Level
- RCL $279.89
- ZTS $168.83
- Average True Range (ATR)
- RCL 6.13
- ZTS 3.41
- MACD
- RCL -1.27
- ZTS -1.67
- Stochastic Oscillator
- RCL 71.43
- ZTS 12.41
About RCL Royal Caribbean Cruises Ltd.
Royal Caribbean is the world's second-largest cruise company, operating 66 ships across five global and partner brands in the cruise vacation industry. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises. The selection of brands in the portfolio allows Royal to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in 2021 and plans to launch its new Celebrity River Cruise brand in 2027.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.